Literature DB >> 18948699

Paroxysmal non-kinesigenic dyskinesia caused by the mutation of MR-1 in a large Polish kindred.

Andrzej Friedman1, Beata Zakrzewska-Pniewska, Izabela Domitrz, Hsien-Yang Lee, Louis Ptacek, Hubert Kwiecinski.   

Abstract

Paroxysmal non-kinesigenic dyskinesia (PNKD) is a clinical syndrome of sudden involuntary movements, mostly of dystonic type, which may be triggered by alcohol or coffee intake, stress and fatigue. The attacks of PNKD may consist of various combinations of dystonia, chorea, athetosis and balism. They can be partial and unilateral, but mostly the hyperkinetic movements are bilateral and generalized. We present a large Polish family with 7 symptomatic members of the family in 6 generations. In all affected persons, the onset of clinical symptoms was in early childhood. All male cases showed an increase in severity and frequency of the attacks with ageing, while the only living female patient noticed an improvement of PNKD during both her pregnancies and also after menopause. In addition, at the age of 55 years, she developed symptoms of Parkinson's disease with good response to levodopa treatment. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948699     DOI: 10.1159/000165348

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

1.  Preliminary study on pathogenic mechanism of first Chinese family with PNKD.

Authors:  Feng Chen; Shaohui Zhang; Tinghong Liu; Liu Yuan; Yangshuo Wang; Guojun Zhang; Shuli Liang
Journal:  Transl Neurosci       Date:  2022-06-09       Impact factor: 1.264

Review 2.  The clinical and genetic heterogeneity of paroxysmal dyskinesias.

Authors:  Alice R Gardiner; Fatima Jaffer; Russell C Dale; Robyn Labrum; Roberto Erro; Esther Meyer; Georgia Xiromerisiou; Maria Stamelou; Matthew Walker; Dimitri Kullmann; Tom Warner; Paul Jarman; Mike Hanna; Manju A Kurian; Kailash P Bhatia; Henry Houlden
Journal:  Brain       Date:  2015-11-23       Impact factor: 13.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.